Charlotte F McDonagh

Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment.

Jennifer B. Webster, Stephen C Alley, P. Carter, 2006, Protein engineering, design & selection : PEDS.

Computational Modeling of ERBB2-Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors

Daniel C Kirouac, Ulrik B Nielsen, Johanna Lahdenranta, 2013, Science Signaling.